Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kölbl

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2021
[Radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : A multicentre phase III trial]Christoph Süß, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2018
[Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline]Christoph Süß, Oliver Kölbl
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860)Dirk Vordermark, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2017
[The role of pelvic irradiation in node-negative prostate adenocarcinoma remains unclear : Long-term results from the GETUG-01 study]Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 16, 2015
[Hodgkin's lymphoma during childhood and adolescence: parenthood rates not lower after radiation treatment outside the pelvis]Matthias Günther Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2014
[Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study]Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2005
[The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients]Barbara Dietl, Christof Schäfer, Oliver Kölbl
Radiation Oncology (London, England)|December 18, 2012
5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?Felix Steger, Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2009
Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arcJudith Alvarez Moret, Oliver Kölbl, Ludwig Bogner
Radiation Oncology (London, England)|August 3, 2011
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?Matthias G Hautmann, Matthias Hipp, Oliver Kölbl
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2021
[Radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : A multicentre phase III trial]Christoph Süß, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2018
[Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline]Christoph Süß, Oliver Kölbl
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860)Dirk Vordermark, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2017
[The role of pelvic irradiation in node-negative prostate adenocarcinoma remains unclear : Long-term results from the GETUG-01 study]Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 16, 2015
[Hodgkin's lymphoma during childhood and adolescence: parenthood rates not lower after radiation treatment outside the pelvis]Matthias Günther Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2014
[Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study]Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2005
[The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients]Barbara Dietl, Christof Schäfer, Oliver Kölbl
Radiation Oncology (London, England)|December 18, 2012
5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?Felix Steger, Matthias G Hautmann, Oliver Kölbl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2009
Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arcJudith Alvarez Moret, Oliver Kölbl, Ludwig Bogner
Radiation Oncology (London, England)|August 3, 2011
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?Matthias G Hautmann, Matthias Hipp, Oliver Kölbl
Pageof 8